Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways.
about
Central sensitivity syndromes: mounting pathophysiologic evidence to link fibromyalgia with other common chronic pain disordersExploring Genetic Susceptibility to FibromyalgiaAnticonvulsant Effect of Guaifenesin against Pentylenetetrazol-Induced Seizure in MiceElevated insular glutamate in fibromyalgia is associated with experimental painβ2- and β3-adrenergic receptors drive COMT-dependent pain by increasing production of nitric oxide and cytokinesExcessive peptidergic sensory innervation of cutaneous arteriole-venule shunts (AVS) in the palmar glabrous skin of fibromyalgia patients: implications for widespread deep tissue pain and fatigue.Novel pharmacotherapy for fibromyalgia.The biochemical origin of pain: the origin of all pain is inflammation and the inflammatory response. Part 2 of 3 - inflammatory profile of pain syndromes.Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome.Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres.Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates.Sodium oxybate: a potential new pharmacological option for the treatment of fibromyalgia syndrome.Correlates of perceived pain-related restrictions among women with fibromyalgiaBiology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome.Combined use of pregabalin and memantine in fibromyalgia syndrome treatment: a novel analgesic and neuroprotective strategy?Clear differences in cerebrospinal fluid proteome between women with chronic widespread pain and healthy women - a multivariate explorative cross-sectional study.Pathophysiology and antioxidant status of patients with fibromyalgia.Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia.Neoteric pharmacotherapeutic targets in fibromyalgia.An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets.Cerebrospinal Fluid Cytokines and Neurotrophic Factors in Human Chronic Pain Populations: A Comprehensive Review.Fibromyalgia: A Critical and Comprehensive Review.Serum levels of high mobility group box 1 protein and its association with quality of life and psychological and functional status in patients with fibromyalgia.Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid.New insights into the genetics of fibromyalgia.Changes in Purines Concentration in the Cerebrospinal Fluid of Pregnant Women Experiencing Pain During Active Labor.Current treatments to counter sleep dysfunction as a pathogenic stimulus of fibromyalgia.Painful After-Sensations in Fibromyalgia are Linked to Catastrophizing and Differences in Brain Response in the Medial Temporal Lobe.Effects of 12-week combined exercise therapy on oxidative stress in female fibromyalgia patients.Absence of contralateral suppression of transiently evoked otoacoustic emissions in fibromyalgia syndrome.Modulation of NMDA Receptor Activity in Fibromyalgia.Neuroinflammation and Central Sensitization in Chronic and Widespread Pain.
P2860
Q24604236-E7EBDCD0-6F16-4D53-B9A0-00F1043392A8Q26797418-2A6E46CC-2EB7-4A7E-9825-CE310530D8ABQ28293894-DD4348F9-39DF-4474-8C46-B0B377626E2DQ33684257-17EA5D13-BBAB-42F8-BB97-B5BE985F6B96Q33863868-E6F38747-0C92-4D4D-B913-B0E947FE3EDEQ34345848-8B5D3206-B6C1-42BF-813E-23D8FC8AE8CEQ34628135-80BF1AF4-2D29-4A81-A137-F5957C817C3DQ34668480-B7244324-078A-47B3-BABD-744B4810A12BQ34897360-C0B80181-7686-409D-BD56-C791884A2C04Q35553892-C55C3CE0-AB16-474A-B536-CEA122E42E93Q35846195-17198209-EA3E-4BAE-BCCA-F29464AEFB38Q36056960-8EFA4757-38CB-4AF5-B987-42CC5EE87758Q36515967-267EC0AF-9351-4300-845B-0DCD7299529FQ36955343-CA9F2CF4-9E26-469A-84F4-71D93DF0D793Q37337235-EAC32289-0996-4FCD-8A3D-2DFE11325CB8Q37709546-B6A32AC6-F6BE-46E0-8376-BCFFFE9335C2Q37727078-9A3EEE5C-0E18-4621-B889-33D176108D0EQ37915359-F45D8A71-8A9C-4FB4-BE41-4AB2819CA4D7Q37929796-8643B973-2237-4EAA-BB7B-1DB7649DEA43Q38167857-3FD66E8F-8E01-4ED3-8213-7773AE2E6DD8Q38263540-F4549269-1112-4B0A-AFE6-733308FA2D4EQ38601633-0AD7BD40-C929-4880-9B18-7E78662027D9Q43530242-60F7FFEC-3330-42D3-B289-6A33191FA87FQ44380439-1C73D9FB-9722-4428-9F0B-5BCB859C5CE5Q45957029-638F260F-B43E-4F11-A73B-9B6D62824828Q47648159-0BBD77D3-486A-48C3-BA9A-FE3AC965B51EQ47845604-831152EB-C764-4DBF-ABFA-153878E0ACFDQ48260773-A622EAE0-BD52-4643-809A-255184472C52Q48338683-B5F26D54-CF6B-4DFC-85EF-66E6AA5CB931Q50452952-D0B43B91-A951-47E3-8AC8-316A1525BC07Q52093964-97477BAE-D4D5-4C3E-ACB7-3C2BD6D0CB67Q52692785-D54CEB97-059E-4D64-A711-FDD046ED6049
P2860
Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Changes in the concentrations ...... ons for nitric oxide pathways.
@ast
Changes in the concentrations ...... ons for nitric oxide pathways.
@en
type
label
Changes in the concentrations ...... ons for nitric oxide pathways.
@ast
Changes in the concentrations ...... ons for nitric oxide pathways.
@en
prefLabel
Changes in the concentrations ...... ons for nitric oxide pathways.
@ast
Changes in the concentrations ...... ons for nitric oxide pathways.
@en
P2093
P1433
P1476
Changes in the concentrations ...... ons for nitric oxide pathways.
@en
P2093
Giovengo SL
Michalek JE
Russell IJ
P304
P356
10.1016/S0304-3959(00)00284-0
P407
P577
2000-08-01T00:00:00Z